TNM Stages and Prognostic Features of Colorectal and Mucinous Adenocarcinoma Patients: A Meta Analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3427-3430

  Chen, Jing Xiang ^a   Tang, Xu Dong ^b   Xiang, De Bing ^c   Dong, Xiao Ling ^c   Peng, Fang Yi ^a   Sun, Gui Yin ^a,c  

^a Jiangjin Central Hospital   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Department of Oncology ^*  (China)

Author keywords

Meta analysis; Mucinous colorectal adenocarcinoma; Prognosis; Tnm

Indexed keywords

EID: 84873596367     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3427     Document Type: Article

References (39)

1. Catalano V, Loupakis F, Graziano F, et al (2009). Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first- line oxaliplatin- and /or irinotecan-based chemotherapy. Br J Cancer, 100, 881-7
2. Catalano V, Loupakis F, Graziano F, et al (2011). Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol, 23, 135-41
3. Cerottini JP, Caplin S, Pampallona S, Givel JC (1999). Prognostic factor s in colorectal cancer. Oncol Rep, 6, 409-14
4. Chen JS, Hsieh PS, Hung SY, et al (2004). Clinical signifi cance of signet ring cell rectal carcinoma. Int J Colorectal Dis, 19, 102-7
5. Chiang JM, Yeh CY, Changchien CR, et al (2010). Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups. Int J Colorectal Dis, 25, 941-7
6. Consorti F, Lorenzotti A, Midiri G, et al (2000). Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case control study. J Surg Oncol, 73, 70-4
7. Cusack JC, Giacco GG, Cleary K, et al (1996). Survival factors in 186 patients younger than 40 years old with colorectal ad nocarcinoma. J Am Coll Surg, 183, 105-12
8. Du W, Mah JTL, Lee J, et al (2004). Incidence and survival of mucinous adenocarcinoma of the colorectum: a populationbased study from an Asian country. Dis Colon Rectum, 47, 78-85
9. Enriquez JM, Diez M, Tobaruela E, et al (1998). Clinical, histopatho logical, cytogenetic and prognostic differences between mucinous andnonmucinous colorectal adenocarcinomas. Rev Esp Enferl Dig, 90, 568-72
10. Farhat MH, Barada KA, Tawil AN, et al (2008). Effect of mucin productio non survival in colorectal cancer: a case control study. World J Gastroenterol, 14, 6981-5
11. Ghabeljoo M, Jafarabadi MA, Mohammadi SM, et al (2011). Patterns of survival for anatomical sites of colorectal cancer with shift to advanced lesions in Iran. Asian Pac J Cancer Prev, 12, 1225-31
12. Greenson JK, Huang SC, Herron C, et al (2009). Pathologic predictors of microsatellite instability in colorecta l cancer. Am J S urg Pathol, 33, 126-33
13. Grillo-Ruggieri F, Mantello G, Berardi R, et al (2007) Mucinousrectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. Dis Colon Rectum, 50, 1594-603
14. Hill DA, Furman WL, Billups CA, et al (2007). Colorectal carcinoma in child hood and adolescence: a clinicopathologic review. J Clin Oncol, 25, 5808-14
15. Huang GL, Guo HQ, Yang F, et al (2012). Activating transcription factor 1 is a prognostic marker of colorectal cancer. Asian Pac J Cancer Prev, 13, 1053-7
16. Hyngstrom JR, Hu C-Y, Xing Y, et al (2012). Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the national cancer data base. Ann Surg Oncol, 2012 Apr 4. [Epub ahead of print]
17. Jass JR, Sobin LH. Histologic Typing of Intestinal Tumours (1989). 2nd edn. Berlin: Springer-Verlag, 1989
18. Jivapaisarnpong P, Boonthongtho K (2011). Clinicopathological characteristics of mucinous and non- mucinous adenocarcinoma in the colon andrectum in Rajavithi Hospital, Thailand. J Med Assoc Thai, 94, S41-5.
19. Kanemitsu Y, Kato T, Hirai T, et al (2003). Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum, 4, 160-7
20. Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY (2005). A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum, 48, 1161-8
21. Langner C, Harbaum L, Pollheimer MJ, et al (2012). Mucinous differentiation in colorectal cancer-indicator of poor prognosis? Histopathology, 60, 1060-72
22. Lee WS, Chun HK, Lee WY, et al (2007). Treatment outcomes in patients with signet ring cell carcinoma of the colorectum. Am J Surg, 194, 294-8
23. Min BS, Kim NK, Ko YT, et al (2009). Clinicopathological features of signetring cell carcinoma of the colon and rectum: a case - matched study. Hepatogastroenterology, 56, 984-8
24. Negri FV, Wotherspoon A, Cunningham D, et al (2005). Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Ann Oncol, 16, 1305-10
25. Nozoe T, Anai H, Nasu S, et al (2000). Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol, 75, 103-7
26. Pande R, Sunga A, Levea C, et al (2008). Significance of signetring cells in patients with colorectal cancer. Dis Colon Rectum, 51, 50-5
27. Papadopoulos VN, Michalopoulos A, Netta S, et al (2004). Prognostic signi fi cance of mucinous component in colorectal carcinoma. Tech Coloproctol, 8, S123-5
28. Safaee A, Moghimi-Dehkordi B, Fatemi SR et al (2010). Characteristics of colorectal mucinous adenocarcinoma in Iran. Asian Pac J Cancer Prev, 11, 1373-5
29. Sengul N, Wexner SD, Woodhouse S, et al(2006). Effects of radiotherapy on different histopathological types of rectal carcinoma. Colorectal Dis, 8, 283-8
30. Song W, Wu SJ, He YL, et al (2009). Clinicopathologic features and survival of patients with colorectal mucinous, signetring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J (Engl). 122. 1486-91
31. Sultan I, Rodriguez - Galindo C, El- Taani H, et al (2010) Distinct features of colorectal cancer in children and adolescents a population-based study of 159 cases. Cancer, 116, 758-65
32. Sun XF, Carstensen JM, Stal O, et al (1996). Interrelations of clinicopathologic variables and their prognostic value in colorectal adenocarcinoma. APMIS, 104, 35-8
33. Verhulst J, Ferdinande L, Demetter P, et al (2012). Mucinous subtype as prognostic factor in colorectal cancer:a systematic review and meta-analysis. J Clin Pathol, 65, 381-8
34. Wu CS, Tung SY, Chen PC, et al (1996). Clinicopathological study of colorectal muc ino uscarcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol, 11, 77-81
35. Xie L, Villeneuve PJ, Shaw A (2009). Survival of patients diagnosed with either colorectal mucinous or non - mucinous adenocarcinoma: a population- based study in Canada. Int J Oncol, 34, 1109-15
36. Yamaguchi T, Taniguchi H, Fujita S, et al (2012). Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma. Histopathology Mar 27. doi: 10.1111/j.1365-2559.2012.04235.x
37. Ye S, Liu X, Wang Q (2002). Colon mucinous adenocarcinoma:107 cases report. J Fujian Med, 24, 12-3
38. You JF, Hsieh LL, Changchien CR, et al (2006). Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients. Clin Cancer Res, 12, 4244-50
39. Zhen M, Li J, Zhou L (2005). Pathological features and prognosis of colon mucinous adenocarcinoma. J China Oncol, 15, 383-6